BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12446461)

  • 1. Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.
    Pagel JM; Hedin N; Subbiah K; Meyer D; Mallet R; Axworthy D; Theodore LJ; Wilbur DS; Matthews DC; Press OW
    Blood; 2003 Mar; 101(6):2340-8. PubMed ID: 12446461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.
    Sharkey RM; Behr TM; Mattes MJ; Stein R; Griffiths GL; Shih LB; Hansen HJ; Blumenthal RD; Dunn RM; Juweid ME; Goldenberg DM
    Cancer Immunol Immunother; 1997 May; 44(3):179-88. PubMed ID: 9191878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies.
    Dillman RO
    Clin Exp Med; 2006 Mar; 6(1):1-12. PubMed ID: 16550338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model.
    Orozco JJ; Balkin ER; Gooley TA; Kenoyer A; Hamlin DK; Wilbur DS; Fisher DR; Hylarides MD; Shadman M; Green DJ; Gopal AK; Press OW; Pagel JM
    PLoS One; 2014; 9(12):e113601. PubMed ID: 25460570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avidin chase can reduce myelotoxicity associated with radioimmunotherapy of experimental liver micrometastases in mice.
    Sato N; Saga T; Sakahara H; Nakamoto Y; Zhao S; Kuroki M; Iida Y; Endo K; Konishi J
    Jpn J Cancer Res; 2000 Jun; 91(6):622-8. PubMed ID: 10874215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunotherapy of small-cell lung cancer xenografts using 131I-labelled anti-NCAM monoclonal antibody 123C3.
    Kwa HB; Verhoeven AH; Storm J; van Zandwijk N; Mooi WJ; Hilkens J
    Cancer Immunol Immunother; 1995 Sep; 41(3):169-74. PubMed ID: 7553686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody.
    Kobayashi H; Sakahara H; Endo K; Hosono M; Yao ZS; Toyama S; Konishi J
    Jpn J Cancer Res; 1995 Mar; 86(3):310-4. PubMed ID: 7744702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative autoradiographic evaluation of the influence of protein dose on monoclonal antibody distribution in human ovarian adenocarcinoma xenografts.
    Yang FE; Brown RS; Koral KF; Clavo AC; Jackson GA; Wahl RL
    Cancer Immunol Immunother; 1992; 35(6):365-72. PubMed ID: 1394341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis.
    Chandler CS; Bell MM; Chung SK; Veach DR; Fung EK; Punzalan B; Burnes Vargas D; Patel M; Xu H; Guo HF; Santich BH; Zanzonico PB; Monette S; Nash GM; Cercek A; Jungbluth A; Pandit-Taskar N; Cheung NKV; Larson SM; Cheal SM
    Mol Cancer Ther; 2022 Jan; 21(1):125-137. PubMed ID: 34667111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of an antibody to CD74 (MHC class II invariant chain) to human B cell lymphoma xenografts in nude mice.
    Shih L; Ong GL; Burton J; Mishina D; Goldenberg DM; Mattes MJ
    Cancer Immunol Immunother; 2000 Jul; 49(4-5):208-16. PubMed ID: 10941903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretargeting: A Path Forward for Radioimmunotherapy.
    Cheal SM; Chung SK; Vaughn BA; Cheung NV; Larson SM
    J Nucl Med; 2022 Sep; 63(9):1302-1315. PubMed ID: 36215514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination radioimmunotherapy and chemoimmunotherapy involving different or the same targets improves therapy of human pancreatic carcinoma xenograft models.
    Sharkey RM; Karacay H; Govindan SV; Goldenberg DM
    Mol Cancer Ther; 2011 Jun; 10(6):1072-81. PubMed ID: 21467164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects.
    Chakraborty M; Gelbard A; Carrasquillo JA; Yu S; Mamede M; Paik CH; Camphausen K; Schlom J; Hodge JW
    Cancer Immunol Immunother; 2008 Aug; 57(8):1173-83. PubMed ID: 18256832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence mounts for the efficacy of radioimmunotherapy for B-cell lymphomas.
    Press OW
    J Clin Oncol; 2008 Nov; 26(32):5147-50. PubMed ID: 18854559
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma.
    Westrøm S; Bønsdorff TB; Abbas N; Bruland ØS; Jonasdottir TJ; Mælandsmo GM; Larsen RH
    PLoS One; 2016; 11(10):e0165382. PubMed ID: 27776176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria.
    Bettegowda C; Dang LH; Abrams R; Huso DL; Dillehay L; Cheong I; Agrawal N; Borzillary S; McCaffery JM; Watson EL; Lin KS; Bunz F; Baidoo K; Pomper MG; Kinzler KW; Vogelstein B; Zhou S
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15083-8. PubMed ID: 14657371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a monoclonal antibody recognizing the heavily glycosylated CD45 protein and its application on identifying circulating tumor cells.
    Zhang W; Li Z; Wang Z; Yue C; Zheng H; Li R; Zhou M; Hu Z; Wei Z; Li Q
    PLoS One; 2018; 13(2):e0192506. PubMed ID: 29425242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearing and Masking Agents in Pretargeting Strategies.
    Staudt M; Herth MM
    Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and
    Orozco JJ; Kenoyer AL; Lin Y; O'Steen S; Guel R; Nartea ME; Hernandez AH; Hylarides MD; Fisher DR; Balkin ER; Hamlin DK; Wilbur DS; Orcutt KD; Wittrup KD; Green DJ; Gopal AK; Till BG; Sandmaier B; Press OW; Pagel JM
    Mol Cancer Ther; 2020 Dec; 19(12):2575-2584. PubMed ID: 33082277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer.
    Li Y; Chyan MK; Hamlin DK; Nguyen H; Vessella R; Wilbur DS
    Nucl Med Biol; 2021 Jan; 92():217-227. PubMed ID: 32409263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.